Gyre Therapeutics
is a California-based biopharmaceutical company that researches and develops hydronidone to treat metabolic dysfunction-associated steatohepatitis... Read moreGyre Therapeutics
is a California-based biopharmaceutical company that researches and develops hydronidone to treat metabolic dysfunction-associated steatohepatitis... Read more
News
Mar 31, 2025
GlobalNewswire
Press Release: Gyre Therapeutics : Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
Mar 18, 2025
Owler
Gyre Therapeutics, Inc.: Gyre Therapeutics's employee count changed from 391 in Dec 2023 to 574 in Dec 2024
Mar 17, 2025
Benzinga
Gyre Therapeutics: Gyre Therapeutics Q4 EPS $0.00 Up From $(1.39...
Mar 17, 2025
Marketscreener
Gyre Therapeutics: Gyre Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
Mar 17, 2025
Investing.com
Gyre Therapeutics: Gyre Therapeutics offers weak 2025 revenue guidance By Investing.com
Nov 14, 2024
Owler
Gyre Therapeutics, Inc.: Gyre Therapeutics's revenue changed from $55.63M in Jun 2024 to $78.68M in Sep 2024
Nov 13, 2024
Marketscreener
Gyre Therapeutics: Gyre Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Oct 22, 2024
GlobeNewswire
Press Release: Gyre Therapeutics : Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
Oct 01, 2024
Yahoo
Gyre Therapeutics: Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
Aug 13, 2024
Benzinga
Gyre Therapeutics: Gyre Therapeutics Q2 EPS $0.01 Down From $0.0...
Gyre Therapeutics Competitors
1
2
3
4
5
6
7
8
9